The Role of Central Venous Oxygen Saturation (ScvO2) as an Indicator of Blood Transfusion in the Critically Ill
Launched by SZEGED UNIVERSITY · Apr 28, 2017
Trial Information
Current as of July 22, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult (\>18 y)
- • 2. Critically ill anemic but hemodynamically stable patients treated on the ICU in whom transfusion is considered by the attending physician
- • 3. Routine ICU monitoring: invasive blood pressure, CVC, hourly urine output
- • 4. Anemia is defined as Hb\<100 g/L
- 5. Hemodynamic stability is defined as:
- • 1. heart rate (HR)\<100/min,
- • 2. mean arterial pressure (MAP)\>60 mmHg
- • 3. no or "minimal" requirement of noradrenaline (NA): compensation for sedation not exceeding 5 µg/min
- 4. stable homeostasis:
- • i. pH: 7.30-7.45 ii. HCO3 \> 20 mmol/L iii. lactate \< 2 mmol/L e. normal hourly urine output for the last 2 hours not facilitated by diuretics: \>0.5ml/kg/h
- • 6. Central venous catheter in situ (position in the v. cava superior confirmed by chest x-ray)
- Exclusion Criteria:
- • 1. Pregnancy
- • 2. Head injury requiring ICP monitoring guided control of ICP
- • 3. Shock of any origin
- • 4. Patients with heart failure
- • 5. Patients with renal failure
About Szeged University
Szeged University, a prestigious institution located in Hungary, is a leading center for medical and clinical research. With a commitment to advancing health sciences and improving patient outcomes, the university collaborates with various healthcare professionals and institutions to conduct innovative clinical trials. The university's research initiatives are supported by state-of-the-art facilities and a multidisciplinary team, ensuring rigorous methodologies and adherence to ethical standards. Through its clinical trial sponsorship, Szeged University aims to contribute valuable insights to the medical community and enhance therapeutic approaches across diverse health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Szeged, Csongrád, Hungary
Budapest, , Hungary
Szeged, , Hungary
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials